Literature DB >> 28506898

Chromane isolated from leaves of Dillenia indica improves the neuronal dysfunction in STZ-induced diabetic neuropathy.

Navpreet Kaur1, Lalit Kishore1, Randhir Singh2.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: According to the Indian traditional medicine, Dillenia indica L. has shown therapeutic efficacy in various diseases. Fruits and leaves of the plant possess anti-oxidant and anti-inflammatory properties. Reactive oxygen species, formation of advanced glycation end products (AGEs) and apoptosis are implicated in the pathogenesis of diabetic neuropathy. AIM OF THE STUDY: The aim of the present study was to explore the effect of D. indica and its isolate, chromane (CR), on thermal and mechanical hyperalgesia, allodynia, MNCV and oxidative-nitrosative stress in streptozotocin-induced experimental diabetes.
MATERIAL AND METHODS: Diabetes was induced by intraperitoneal administration of Streptozotocin (STZ; 65mg/kg) for the development of diabetic neuropathy. Chronic treatment with DAE (100, 200 and 400mg/kg, p.o.) and CR (5 and 10mg/kg, p.o.) for 30 days was started from the 60th day of STZ administration. Development of neuropathy was evident from a marked hyperalgesia and allodynia; reduced MNCV associated with increased formation of AGEs and reactive oxygen species.
RESULTS: significantly attenuated behavioral and biochemical changes associated with diabetic neuropathy. Present study suggested that DAE and CR ameliorated hyperglycemia and diabetic neuropathic pain via modulation of oxidative-nitrosative stress and reduction in AGEs formation in the diabetic rats.
CONCLUSION: Thus D. indica might be beneficial in chronic diabetics, ameliorate the progression of diabetic neuropathy and may also find application in diabetic neuropathic pain.
Copyright © 2017 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Advanced glycation end-products; Dillenia indica; Nitrosative stress; Oxidative stress

Mesh:

Substances:

Year:  2017        PMID: 28506898     DOI: 10.1016/j.jep.2017.05.018

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  6 in total

Review 1.  Polyphenols for diabetes associated neuropathy: Pharmacological targets and clinical perspective.

Authors:  Rozita Naseri; Fatemeh Farzaei; Sajad Fakhri; Fardous F El-Senduny; Miram Altouhamy; Roodabeh Bahramsoltani; Farnaz Ebrahimi; Roja Rahimi; Mohammad Hosein Farzaei
Journal:  Daru       Date:  2019-07-27       Impact factor: 3.117

2.  Effect of Kaempferol isolated from seeds of Eruca sativa on changes of pain sensitivity in Streptozotocin-induced diabetic neuropathy.

Authors:  Lalit Kishore; Navpreet Kaur; Randhir Singh
Journal:  Inflammopharmacology       Date:  2017-11-20       Impact factor: 4.473

3.  Hydrogen Sulfide Inhibits High Glucose-Induced Neuronal Senescence by Improving Autophagic Flux via Up-regulation of SIRT1.

Authors:  Lei Wu; Ying Chen; Chun-Yan Wang; Yi-Yun Tang; Hong-Lin Huang; Xuan Kang; Xiang Li; Yu-Rong Xie; Xiao-Qing Tang
Journal:  Front Mol Neurosci       Date:  2019-08-20       Impact factor: 5.639

Review 4.  Therapeutic Benefit of Dillenia indica in Diabetes and Its Associated Complications.

Authors:  Parul Kamboj; Narayan C Talukdar; Sanjay K Banerjee
Journal:  J Diabetes Res       Date:  2019-11-23       Impact factor: 4.011

5.  Dexmedetomidine attenuates P2X4 and NLRP3 expression in the spine of rats with diabetic neuropathic pain.

Authors:  Liu Kang; Huang Yayi; Zhou Fang; Zhao Bo; Xia Zhongyuan
Journal:  Acta Cir Bras       Date:  2019-12-20       Impact factor: 1.388

Review 6.  Therapeutic Potential of Polyphenols in the Management of Diabetic Neuropathy.

Authors:  Md Tanvir Kabir; Nuzhat Tabassum; Md Sahab Uddin; Faissal Aziz; Tapan Behl; Bijo Mathew; Md Habibur Rahman; Raushanara Akter; Abdur Rauf; Lotfi Aleya
Journal:  Evid Based Complement Alternat Med       Date:  2021-05-13       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.